All In Biotech

Free tool

FAERS Monitor: Lumryz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214755 or its brand name (Lumryz, Sodium Oxybate). Reports on generic versions are filed under their own applications.

Reports

5,012

Serious

1,731

35% of reports

Hospitalization

512

Death reported

123

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • somnolence896
  • insomnia872
  • middle insomnia807
  • nausea748
  • product dose omission issue645
  • fatigue612
  • drug ineffective567
  • initial insomnia454
  • dizziness405
  • anxiety401
  • intentional dose omission384
  • feeling abnormal377
  • nocturia369
  • vomiting363
  • headache340

Reports by year received

View as table
YearReports
20043
20082
20092
201027
201115
201212
20135
20145
201517
201616
201722
201852
201939
202019
202128
202228
2023551
20242,469
20251,233
2026467

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,147 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
initial insomniaSignal454194.2177.583,270
middle insomniaSignal807189.5177.6144,747
nocturiaSignal369131.5119.046,229
intentional dose omissionSignal38457.352.020,921
somnolenceSignal89618.817.715,118
insomniaSignal87213.813.010,422
product dose omission issueSignal6459.28.64,777
feeling abnormalSignal3776.66.01,807
anxietySignal4015.95.41,655
nauseaSignal7484.03.71,721
dizzinessSignal4053.43.1703
fatigueSignal6123.33.11,016
vomitingSignal3633.22.9573
headacheSignal3402.32.1249
drug ineffective5671.81.7217

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.